A clinical trial listing related to substance P was updated on August 7, 2026. The study, titled "Long-Term Follow-Up of Survivors of Pediatric Cushing Disease," is registered under identifier NCT03831958.
The trial's current status is listed as recruiting. No phase information was provided in the trial record. Substance P remains classified as an unapproved compound for research use, and this listing does not indicate any change to that regulatory status.
No outcome data, interim findings, or results have been reported for this trial as of the update date. The listing reflects only the recruitment status and title of the study as registered on ClinicalTrials.gov. No efficacy or safety conclusions can be drawn from a recruiting status alone.
Readers interested in this trial can view the full registration details, eligibility criteria, and any future updates through the official ClinicalTrials.gov record linked with this brief. For additional background on substance P and its research classification, see the compound overview.